The proposed health benefits of cocoa (Theobroma cacao) have been known for centuries. The Incas
considered cocoa to be the drink of the gods, hence its scientific name
originating from the Greek words theo
(god) and broma (drink). Cocoa
consumption dates back to 1600 BCE and was introduced from the New World to the Europeans in the 16th
century. Since this time, the chocolate industry has grown drastically, and
cocoa is processed in many different ways. Several commonly purported health
benefits of cocoa consumption include improvements in heart function,
digestion, and kidney and bowel function. It is important to distinguish
between the natural product cocoaand
the processed product chocolate. The
authors note that the effects of cocoa reported in this paper may not apply to
chocolate. The objective was to review the "clinically relevant
cardiovascular effects of cocoa" with a focus on the potential mechanisms
responsible for the responses to cocoa and the potential clinical implications
of its consumption.
The first epidemiologic evidence of the cardiovascular
health benefits of cocoa was observed in the Kuna Indians, indigenous to
islands off the coast of Panama.
The Kunas consume "enormous" amounts of cocoa, sometimes with added
salt, yet have "markedly lower" cardiovascular mortality than other
Pan-American citizens and no age-dependent increase in blood pressure or
decline in kidney function. The mechanism is environmental and not genetic,
because these benefits are lost after migration to urban Panama City where cocoa is replaced with
lower flavanol content foods. The Iowa Women's Health Study (34,489
postmenopausal women with a 16-year follow-up) found that consumption of high
flavonoid foods was associated with a decrease in coronary disease. In the
Dutch Zutphen Study, cocoa intake specifically was associated with a 50%
reduced risk of cardiovascular mortality between the highest and lowest
quintile of intake in 470 elderly men. These epidemiologic data led to the
hypothesis that the health benefits of cocoa may be linked to its constituent
flavonoids (e.g., flavanols and
procyanidins)—a subgroup of polyphenols. Both the flavanol content and the
total antioxidant capacity have been shown to increase in plasma after cocoa
consumption.
Cocoa flavanols (also known as flavan-3-ols) can be found in
high concentrations in grape juice, wine, various berries, and especially
cocoa. In cocoa, the flavanols consist of monomers like epicatechin, dimmers,
and oligomers; the latter are called procyanidins and are responsible for the
bitter flavor of cocoa. Conventional chocolate processing can markedly reduce
the levels of flavanols. Detrimental effects to flavanol content include
fermentation and roasting. The location where the cacao beans are grown also
determines the flavanol content.
Functional impairment of the
endothelium, the layer of cells lining the blood
vessels and heart, is a first step in atherosclerotic changes and is
positively affected by nitric oxide.Cocoa
consumption has been shown to affect nitric oxide levels, increasing its
production and metabolites in humans. Endothelial function and circulation were
concurrently improved in a number of studies. Cocoa flavanols also improved
circulation to the brain in elderly subjects, suggesting protection against
dementia and stroke. Platelet dysfunction is another indicator of
atherosclerotic disease, and several in vivo studies showed that cocoa inhibits
platelet aggregation and adhesion. Cocoa
was also correlated with lowered blood pressure in a number of studies, with some
evidence for reduced insulin resistance. It also displayed antioxidant
properties, increasing overall antioxidant capacity and decreasing several
markers of oxidation. Cocoa butter, the fat portion of cocoa, appears not to
adversely affect cholesterol.
Many positive effects of cocoa intake on the cardiovascular
system have been documented, including a reduction in platelet aggregation and
improvements in endothelial function, blood pressure, insulin resistance, and
blood lipids. Current evidence suggests that these beneficial health effects
are attributed to the flavanol content of cocoa, particularly epicatechin,
which increases the bioavailability of nitric oxide. However, it should be
noted that cocoa contains many other active substances, including theobromine
and magnesium. In studies, the exact content of flavanols and plasma flavanol
concentration should be reported. Furthermore, wholesale recommendations to
consume flavanol supplements are premature because of the potential pro-oxidant
effects of large quantity intake. Commercially available chocolate can have a
high sugar and fat content, which can induce weight gain and dental caries,
whereas cocoa has a low sugar and fat content and is thus preferred.